Pfizer Inc PFE:NYSE

RT Quote | NYSE | USD
Last | 4:00 PM EDT
44.25quote price arrow down-0.21 (-0.47%)
Volume
12,768,594
52 week range
40.94 - 61.71
Loading...
  • Open44.12
  • Day High44.37
  • Day Low43.68
  • Prev Close44.46
  • 52 Week High61.71
  • 52 Week High Date12/20/21
  • 52 Week Low40.94
  • 52 Week Low Date10/13/21

Key Stats

  • Market Cap248.346B
  • Shares Out5.612B
  • 10 Day Average Volume19.92M
  • Dividend1.60
  • Dividend Yield3.62%
  • Beta0.67
  • YTD % Change-25.17

KEY STATS

  • Open44.12
  • Day High44.37
  • Day Low43.68
  • Prev Close44.46
  • 52 Week High61.71
  • 52 Week High Date12/20/21
  • 52 Week Low40.94
  • 52 Week Low Date10/13/21
  • Market Cap248.346B
  • Shares Out5.612B
  • 10 Day Average Volume19.92M
  • Dividend1.60
  • Dividend Yield3.62%
  • Beta0.67
  • YTD % Change-25.17

RATIOS/PROFITABILITY

  • EPS (TTM)5.19
  • P/E (TTM)8.53
  • Fwd P/E (NTM)7.72
  • EBITDA (TTM)42.238B
  • ROE (TTM)37.84%
  • Revenue (TTM)101.132B
  • Gross Margin (TTM)62.21%
  • Net Margin (TTM)29.44%
  • Debt To Equity (MRQ)46.19%

EVENTS

  • Earnings Date11/01/2022
  • Ex Div Date11/03/2022
  • Div Amount0.40
  • Split Date-
  • Split Factor-

Related Video

Two-Minute Drill: GOOGL, MSFT & PFE
VIDEO3:0603:06
Two-Minute Drill: GOOGL, MSFT & PFE

Profile

MORE
Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global...
Albert Bourla Ph.D.
Chairman of the Board, Chief Executive Officer
David Denton
Executive Vice President, Chief Financial Officer
Aamir Malik
Executive Vice President, Chief Business Innovation Officer
Lidia Fonseca Ph.D.
Executive Vice President, Chief Digital and Technology Officer
Douglas Lankler
Executive Vice President, General Counsel
Address
235 E 42ND ST
New York, NY
10017-5703
United States

Top Peers

SYMBOLLASTCHG%CHG
RHHBY
Roche Holding AG
41.73-0.70-1.65%
ABBV
Abbvie Inc
143.33+1.34+0.94%
MRK
Merck & Co Inc
88.39+0.01+0.01%
JNJ
Johnson & Johnson
165.11-0.51-0.31%
NVS
Novartis AG
77.37-0.86-1.10%